Top in hem/onc: Common retirement pitfalls; women underrepresented in trial leadership
Click Here to Manage Email Alerts
Qualified retirement plans are a growing area for liability among all businesses, including medical practices, experts said.
In their latest column, David B. Mandell, JD, MBA, an attorney and founder of the wealth management firm OJM Group, and Adam Braunscheidel, a wealth advisor at OJM Group, explained the four most common potential liability traps in medical practice qualified retirement plans. It was the top story in hematology/oncology last week.
Another top story was about the underrepresentation of women as first authors of randomized controlled trials. Researchers said the findings indicate a need for increased efforts toward inclusion of women as leaders of clinical trials.
Read these and more top stories in hematology/oncology below:
Practice’s retirement can create liability: Four common pitfalls to avoid
Most medical practices nationwide sponsor some type of qualified retirement plan, including 401(k)s, profit-sharing plans, defined benefit plans and hybrid plans. Most physicians do not realize that a growing area of liability for medical practices relates to qualified retirement plans and how they are managed. Read more.
Women notably underrepresented in clinical trial leadership
Women appeared to be significantly underrepresented as first authors of thousands of randomized controlled trials compared with men, according to study results published in Contemporary Clinical Trials. Read more.
New COVID-19 variants have ‘major impact’ on prevention for cancer cell therapy recipients
The FDA recently withdrew its emergency use authorization for Evusheld (tixagevimab plus cilgavimab, AstraZeneca), a combination monoclonal antibody therapy used to prevent COVID-19 among high-risk individuals. Read more.
Physical activity program benefits patients with cancer, survivors
A program that combined physical activity with psychological therapy appeared to improve mental and physical health, as well as quality of life, among patients with cancer and survivors. Read more.
Omission of radiation ‘is an option’ for some older women with early breast cancer
Omission of whole-breast irradiation did not appear to have a negative impact on survival or risk for distant metastases among older women with early-stage hormone receptor-positive breast cancer, according to phase 3 study results. Read more.